The history of James Parkinson and his disease

      James Parkinson (1755-1824) was an English apothecary-surgeon, geologist, paleontologist and political activist. He spent his radical youth in political agitation, later pursuing his medical practice and his interests in medicine and the earth sciences. His 1817 “Essay on the Shaking Palsy” brought together the elements of resting tremor, stiffness and the characteristic station and gait in the illness that he called paralysis agitans. Fragments of the disease can be discerned in ancient Chinese, Indian, Babylonian and Greek texts, but in an 1872 lecture Jean-Martin Charcot added bradykinesia to the cardinal signs and coined the eponym Parkinson’s Disease. Charcot’s school advocated the use of anticholinergic medication. The French neurologist Édouard Brissaud described the characteristic pathology in the substantia nigra, a finding confirmed in 1953 by Greenfield and Bosanquet. Barger and Ewens synthesized dopamine in 1910, but it was not until the late 1950s that neurochemists associated the depletion of dopamine in the substantia nigra with James Parkinson’s disease. When Birkmayer and Hornykiewicz injected the dopamine precursor l-dihydrophenylalanine (levodopa) into patients with Parkinson’s disease in 1961 they found immediate but short-lived improvement. The subsequent development of peripherally-acting dopamine blockers increased levodopa’s absorption into the central nervous system and decreased the frequency of side effects. Invasive techniques, including interruption of the globus pallidus and placement of deep brain electrodes in the midbrain, are contemporary treatments with unsettled indications for their use. James Parkinson’s disease has become a model for combined chemical and surgical attacks on a globally distributed degenerative neurological disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect